OLVIG
Oliver Lagore Vanvalin Investment Group’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.55K | Buy |
+140
| New | +$3.55K | ﹤0.01% | 516 |
|
|
2024
Q4 | $4.51K | Hold |
170
| – | – | ﹤0.01% | 526 |
|
|
2024
Q3 | $4.92K | Sell |
170
-50
| -23% | -$1.45K | ﹤0.01% | 507 |
|
|
2024
Q2 | $6.16K | Buy |
220
+50
| +29% | +$1.4K | ﹤0.01% | 472 |
|
|
2024
Q1 | $4.72K | Sell |
170
-28
| -14% | -$777 | ﹤0.01% | 508 |
|
|
2023
Q4 | $5.7K | Sell |
198
-138
| -41% | -$3.97K | ﹤0.01% | 493 |
|
|
2023
Q3 | $11.1K | Sell |
336
-306
| -48% | -$10.1K | ﹤0.01% | 419 |
|
|
2023
Q2 | $23.5K | Sell |
642
-163
| -20% | -$5.97K | 0.01% | 345 |
|
|
2023
Q1 | $32.8K | Sell |
805
-109
| -12% | -$4.44K | 0.01% | 226 |
|
|
2022
Q4 | $46.8K | Sell |
914
-197
| -18% | -$10.1K | 0.03% | 183 |
|
|
2022
Q3 | $49K | Buy |
1,111
+85
| +8% | +$3.75K | 0.03% | 170 |
|
|
2022
Q2 | $54K | Sell |
1,026
-231
| -18% | -$12.2K | 0.03% | 168 |
|
|
2022
Q1 | $64K | Sell |
1,257
-88,863
| -99% | -$4.52M | 0.04% | 163 |
|
|
2021
Q4 | $5.32M | Buy |
+90,120
| New | +$5.32M | 0.38% | 41 |
|